Abstract
Purpose
Systemic chemotherapy regimens with cisplatinum have been associated with several toxicities. Thus, a loco-regional therapy approach may greatly reduce the toxicity. For this purpose, we designed this experimental study to investigate whether local chemotherapeutic injection is superior to systemic cisplatinum injection for retroperitoneal lymph nodes.
Methods
A total of 48 male Wistar rats were included to the study. Rats were divided into six groups. In the first three groups, systemic applications of cisplatinum, carboplatinum and oxaliplatin were performed, respectively. In the last three, local administration of cisplatinum, carboplatinum and oxaliplatin was performed, respectively. One hour after the chemotherapeutic agent applications, retroperitoneal lymph nodes were dissected and platinum concentrations were analyzed.
Results
When compared with systemic route, achieving higher platinum concentrations in the local chemotherapeutic application groups was the most spectacular result of the study. Serum platinum concentrations were also lower in the local application groups than systemic ones. When we compared local and systemic applications between three chemotherapeutic agents, the most significant concentration difference was seen in carboplatinum group.
Conclusion
The results of this study demonstrate that intralymphatic delivery of cisplatinum, carboplatinum and oxaliplatin leads to higher drug concentrations in the retroperitoneal lymph nodes when compared with intravenous administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Basal S, Irkilata HC, Yildirim I, Sadir S, Korkmaz A, Zor M, Aydur E, Peker AF (2008) Retroperitoneal testicular lymph node mapping in rats: an experimental study. Urol Oncol 26(3):286–290
Belani CP (2004) Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma. Semin Oncol 31(6 Suppl 14):25–33
Cai S, Xie Y, Bagby TR, Cohen MS, Forrest ML (2008) Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate. J Surg Res 147(2):247–252
Carrick S, Ghersi D, Wilcken N, Simes J. (2004) Platinum containing regimens for metastatic breast cancer. Cochrane Database Syst Rev (3):CD003374
Fiorentino MV, Daniele O, Morandi P, Aversa SM, Ghiotto C, Paccagnella A, Fornasiero A (1988) Intrapericardial instillation of platin in malignant pericardial effusion. Cancer 62(9):1904–1906
Follezou JY, Fauchon F, Chiras J (1989) Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase II study. Neoplasma 36(3):349–352
Jacobs SC, Menashe DS (1990) Intraarterial chemotherapy for bladder cancer. Prog Clin Biol Res 350:101–106
Jones RH, Vasey PA (2004) Testicular cancer–management of advanced disease. Lancet Oncol 5(3):146–147
Kasugai H, Kojima J, Tatsuta M, Tanaka S, Okuda S, Sasaki Y, Imaoka S, Fujita M (1988) Intra-arterial infusion and chemo-embolization therapy for hepatocellular carcinoma using lipiodol and cisplatin. Nippon Shokakibyo Gakkai Zasshi 85(2):207–216
Llopis B, Gallego J, Mompo JA, Boronat F, Jimenez JF (1985) Thiotepa versus adriamycin versus cis-platinum in the intravesical prophylaxis of superficial bladder tumors. Eur Urol 11(2):73–78
Mortimer JE, Taylor ME, Schulman S, Cummings C, Weymuller E Jr, Laramore G (1988) Feasibility and efficacy of weekly intraarterial cisplatin in locally advanced (stage III and IV) head and neck cancers. J Clin Oncol 6(6):969–975
Opitz I, Lardinois D, Arni S, Hillinger S, Vogt P, Odermatt B, Rousson V, Weder W (2007) Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment. Eur J Cardiothorac Surg 31(5):773–778
Paiva MB, Bublik M, Castro DJ, Udewitz M, Wang MB, Kowalski LP, Sercarz J (2005) Intratumor injections of cisplatin and laser thermal therapy for palliative treatment of recurrent cancer. Photomed Laser Surg 23(6):531–535
Sersa G, Miklavcic D, Cemazar M, Rudolf Z, Pucihar G, Snoj M (2008) Electrochemotherapy in treatment of tumours. Eur J Surg Oncol 34(2):232–234
Zor M, Yildirim I. (2012) Retroperitoneal lymph node mapping with patent blue dye injection. Is testicular route feasible? Arch Clin Exp Surg. doi:10.5455/aces.20120410111659
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zor, M., Yildirim, I., Basal, S. et al. Intralymphatic delivery of platinum-based chemotherapeutics is possible: an experimental study. J Cancer Res Clin Oncol 138, 1679–1682 (2012). https://doi.org/10.1007/s00432-012-1245-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-012-1245-8